Wizmed Logo

Wizmed White Papers

Read our whitepapers on the pharmaceutical market


Understanding Drug Patents

Nov 2020

Understand the various types of drug patents and drug patent duration

Read the white paper on drug patents

Understanding FDA 483 and Warning Letters

Oct 2020

Understand FDA 483 warning letters and the differences between them

Read the white paper on FDA 483s and warning letters

Why are there drug shortages

Sept 2020

Understand why drug shortages exist

Read why there are drug shortages

Wizmed Reports

Access our reports for details on Active pharmaceutical ingredients, inspection analysis, compounded products and much more in the pharmaceutical space


Analysis of Warning Letters due to COVID-19

July 2020

The FDA has issued 164 warning letters due to companies offering unapproved or misbranded products related to COVID-19. Download or see the list here.

Download the Report

2Q2020 New Active DMFs

July 2020

Every quarter the FDA posts the newly filed, Active Pharmaceutical Ingredients. Read the report to see who has new filings.

Download the Report

1Q2020 New Active DMFs

April 2020

Every quarter the FDA posts the newly filed, Active Pharmaceutical Ingredients. Read the report to see who has new filings.

Download the Report

Pharmedium Product List Filed with FDA

Feb 2020

Given the news of Pharmedium ceasing operations this was a requested report.

Download the Report

CDER Inspection Analysis

June 2019

Analysis of FDA Center for Drug Evaluation (CDER) inspections by country for past 3 years

Download the Report

Aurobindo Inspection Analysis

June 2019

Compilation of Aurobindo/Auromedics inspection record over the past 3 years.

Take me to FDA warning letters